All Products
Research$60

Cartalax (Ala-Glu-Asp Tripeptide)

Cartalax is a synthetic tripeptide bioregulator with the amino acid sequence Ala-Glu-Asp (AED). It belongs to the Khavinson family of short peptide bioregulators developed in Russian research and is derived from sequences found in cartilage-related collagen (notably type XI collagen alpha-1 chain). Supplied as 25mg lyophilized.

Read Research

Product Specifications

  • Sequence: 3 amino acids (Ala-Glu-Asp)
  • Class: Khavinson bioregulator
  • Form: Lyophilized 25mg
  • Documentation available
4.4 / 5.0 rating

Research use only. Not for human or animal use.

Research Summary

  • Cartalax's short three-amino-acid structure allows it to penetrate cells and interact with chromatin in research models.
  • Rat cartilage culture studies have reported increases in cartilage area and chondrocyte proliferation with Cartalax exposure.
  • Gene-expression research has examined effects on COL2A1 (collagen type II), ACAN (aggrecan), and SOX9 anabolic markers.
  • Studies have also examined catabolic markers including MMP-1 and MMP-13 in inflammatory cartilage models.
  • Research is preclinical — limited to in-vitro and rodent models with no Phase II/III human trials as of 2026.

Frequently Asked Questions

Important Disclaimer

This page is for educational and informational purposes only. This product is a research chemical sold for laboratory use only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider. These statements have not been evaluated by the FDA.